AI hype amid weak organic growth; deal conversions key near-term

Delivered YoY growth 2.0%; cc growth claimed vs 2.0% actual is +140% overstatement

Delivered OPM 19.3%; EBIT metric not isolated in financial data provided; margin expansion vs prior year confirmed (220 bps YoY plausible)

Management confirmed $203M deals in Q2; over 50% are AI-led; conversion status ongoing, not yet full revenue recognition

Prior guidance aspired to 16–17% EBIT; delivered 16.3% EBIT (if metric consistent) puts company ahead by couple of quarters; plausible

Management stated $120M annualized EI (Engineering Intelligence) revenue; only ~$30M recognized in Q2 (quarterly run-rate ~$30M × 4 = $120M annualized); claims ~9.5% of revenue is AI-related

Segment growth figures align with reported data; no contradiction identified

Prior call guided 13–15% CAGR, 16–17% EBIT margins; Q2 delivers only 2% organic growth, 16.3% EBIT achieved. Guidance held but execution gap is real.

Q1 mentioned AI as strategic priority; Q2 disclosed $120M annualized EI revenue ($30M Q2 run-rate), >50% of $203M deal wins are AI-led. Concrete number adds credibility.

Q1 narrative was recovery; Q2 acknowledges 'some headwinds' in Europe Auto, expects recovery in 9–12 months vs earlier optimism. Delayed.

Q1 expected Tech return to growth Q2 onwards; Q2 says Tech 'stable/muted' with Med Tech one-time ramp down in Q3, growth from Q4. Earlier guidance missed.

Volatility driven by deal concentration and conversion timing. Segment split into 4 categories (Oil/Gas, Chemicals, Energy, Industrial); large deals are multi-year, staggered revenue ramp. Mix now more granular; focus on AI content across verticals.

Mobility has 4 components: Auto US (in growth mode), T&OH, Aero/Rail (in growth), Auto Europe (challenged but recovery expected next year). Diversification into AI-defined mobility and OEM software underway. Early growth signs in last two quarters.

4 sub-segments: Med Tech (program ramp down Q3, restart Q4), Semcon (growing, differentiated), Tech Infra (deal wins driving growth), Media/Systems/Platforms (muted). Growth from Q4 expected.

One-time $165M gain in Q2; SWC discontinuation effective Q3. Going forward, only continued SWC revenue recognized; operation line standalone thereafter. No significant ongoing business impact.

Macro is pulling back on expansion capex but doubling down on core growth. Client conversations on AI capex very positive; 9–12 months ahead of competition. Mix shift to growth-margin trade-off; deal-driven lumpiness is structural, not temporary.

EBIT margins 16.3% achieved ahead of schedule (prior guidance 16–17%). Wage hikes in Q3, ~50–80 bps impact. Revenue growth, healthy segment mix, operational efficiency, AI productivity gains, disciplined SG&A will sustain 16–17% range.

Wage hikes announced for Q3, 50–80 bps estimated impact. Range to be clarified as quarter progresses. Hikes applied to all employees; focus on profitable growth thereafter.

Yes, trend is clear. Clients doubling down on growth and shifting spend to AI infrastructure, Silicon, Cloud Platforms, Data Centers. LTTS portfolio aligned via Lakshya 31 strategy; AI helps unlock market share vs competition.

AI revenue is EI stack deliverables created and claimed as premium. Not separate line revenue; embedded in project delivery. $120M annualized on ~9.5% of quarterly revenue. Profitability is lever; AI margins improve overall LT trajectory.

6–7 infrastructure layers (physical, electrical, HVAC, GPU, software, observability, agents). Deal sizes vary: $100M = 5–7 years, $50M = 4–5 years, $25M = 3 years, $10M = 2–3 years. LTTS service provider across layers; first wins with OEM/electrical companies; expanding to other layers.

AI revenue annualized $120M. Roughly 50% of $203M deal wins are AI-led; significant portion operationalized in Q2 (~$30M run-rate). Expansion ongoing as deals progress from contract to execution.

Segment delivered +13.4% YoY in Q2; order backlog up YoY; large deals converting. Management reiterates confidence.

Reaffirmed from prior Q1 guidance; however, Q2 actual is 2% organic YoY. Relies on deal conversion and AI revenue ramp-up. Significant gap vs claimed.

Management states regular furloughs and seasonal patterns; H2 expected to see stronger momentum from deal pipeline and conversions. Not quantified.

Achieved 16.3% in Q2, ahead of prior aspiration of mid-16% by couple of quarters. Margin levels in range supported by AI revenue mix, operational efficiency, discipline.

Q3 wage hikes ~50–80 bps impact; management confident mid-16% levels sustainable via growth, AI productivity, SG&A discipline. Hedged on exact range.

Q2 had $203M new TCV but revenue recognition ongoing (~$30M in Q2). Large deal backlog conversion pace uncertain amid macro caution. Missing deal targets could derail 13–15% CAGR narrative.

Auto Europe sub-segment weak; OEMs in restructuring, write-offs underway. Management expects recovery 9–12 months out. Delayed recovery could extend Mobility margin pressure.

Claimed YoY growth 4.8% in constant currency vs actual 2%; a 140% overstatement. Clients are pulling back on expansion capex despite doubling down on core growth. Organic growth is materially weaker than guided 13–15% CAGR narrative suggests.

Q3 wage hikes estimated 50–80 bps margin impact. While management confident in offset via growth and AI, actual impact will depend on deal conversion velocity and pricing realization.

Hi-Tech segment muted; Med Tech program ramp-down in Q3, recovery deferred to Q4+. Semcon, Infra, Media sub-segments are lumpy. Growth dependent on deal wins, not steady-state.